Intelligent Oral Care System with Personalized Calcium-Fluoride Delivery

Publication ID: 24-11857653_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Intelligent Oral Care System with Personalized Calcium-Fluoride Delivery,” Published Technical Disclosure No. 24-11857653_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857653_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,653.

Summary of the Inventive Concept

A next-generation oral care system that leverages advanced technologies to optimize calcium-fluoride delivery for personalized oral care benefits, surpassing the limitations of traditional methods.

Background and Problem Solved

The original patent disclosed a method of providing oral care benefits using a poorly-soluble calcium compound and fluoride. However, this approach has limitations, such as fixed timing and concentration of calcium compound and fluoride introduction, which may not be effective for all individuals. The new inventive concept addresses these limitations by introducing a system that can adapt to individual oral cavity responses and optimize calcium-fluoride delivery for enhanced oral care benefits.

Detailed Description of the Inventive Concept

The new inventive concept comprises a poorly-soluble calcium compound delivery module, a fluoride infusion module, and a data analytics module. The delivery module releases the calcium compound in a controlled manner, while the infusion module introduces fluoride into the oral cavity at a predetermined time interval after the calcium compound release. The data analytics module analyzes user data and oral cavity response to optimize the timing and concentration of calcium compound and fluoride introduction. Additionally, the system may include sensors to monitor oral cavity conditions, microcontrollers to control the release of calcium compound and fluoride, and nanoparticle technology to target specific oral cavity sites for enhanced calcium-bound fluoride deposition.

Novelty and Inventive Step

The new claims introduce a paradigm shift in oral care by integrating advanced technologies, such as data analytics, sensors, and microcontrollers, to create a personalized and adaptive oral care system. The inventive step lies in the combination of these technologies to optimize calcium-fluoride delivery, which is not obvious from the original patent.

Alternative Embodiments and Variations

Alternative embodiments may include variations in the type of sensors used, the algorithm employed by the data analytics module, or the material composition of the calcium compound and fluoride reservoirs. Additionally, the system could be integrated with other oral care devices, such as toothbrushes or mouthwash dispensers, to create a comprehensive oral care platform.

Potential Commercial Applications and Market

The new inventive concept has significant commercial potential in the oral care industry, particularly in the development of premium, high-tech oral care products. The target market includes consumers seeking advanced oral care solutions, dental professionals, and oral care companies looking to differentiate their products and services.

CPC Classifications

SectionClassGroup
A A61 A61K8/21
A A61 A61K8/0204
A A61 A61K8/0216
A A61 A61K8/19
A A61 A61K8/24
A A61 A61K8/44
A A61 A61Q11/00

Field of Art

Oral care technologies, specifically dental treatment methods involving calcium compounds and fluoride delivery systems, with expertise in pharmaceutical formulation, dental chemistry, and medical device design

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degree in dental sciences, chemical engineering, or pharmaceutical sciences, possessing knowledge of oral chemistry, materials science, and medical device development, with understanding of controlled substance delivery mechanisms

Obviousness Rationale

A PHOSITA would recognize that integrating sensor technologies, data analytics, and microcontroller-based delivery systems into the existing oral care method represents a predictable technological evolution. The core method of calcium compound and fluoride interaction remains consistent with the source patent, while the proposed variations merely apply standard engineering techniques to enhance precision and personalization. The fundamental chemical interaction and therapeutic goal remain unchanged, making the technological extensions obvious to one skilled in the art.

Obvious Combinations & Variations

Source Patent Element
Method of administering poorly-soluble calcium compound before fluoride introduction
PTD Variation
Adding microcontroller-based controlled release mechanism for calcium compound and fluoride
Obviousness Reasoning
Automated controlled delivery is a known technique in pharmaceutical sciences, representing a predictable application of existing control technologies to established oral care methods
Source Patent Element
Specific time intervals for calcium and fluoride administration
PTD Variation
Implementing sensor-based dynamic timing adjustment based on oral cavity conditions
Obviousness Reasoning
Real-time monitoring and adaptive delivery are standard design improvements in medical device technologies, representing an obvious extension of existing time-based administration principles
Source Patent Element
List of poorly-soluble calcium compounds
PTD Variation
Introducing nanoparticle-based targeted fluoride delivery
Obviousness Reasoning
Nanoparticle drug delivery is a well-established technique in pharmaceutical sciences, representing a predictable technological enhancement to existing compound interaction methods
Source Patent Element
Oral cavity benefit method using calcium and fluoride
PTD Variation
Data analytics module for personalizing oral care intervention
Obviousness Reasoning
Personalized medical interventions using data analysis are standard practice in modern healthcare technologies, representing an obvious application of known informatics techniques
Source Patent Element
Fluoride and calcium compound interaction mechanism
PTD Variation
Integration with comprehensive oral care platform including multiple delivery devices
Obviousness Reasoning
System integration and multi-device coordination are standard engineering approaches, representing a predictable technological evolution in medical device design
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857653 and the disclosed technological variations, a person having ordinary skill in the art would find the proposed oral care system and method variations obvious and non-patentable. The combination of known techniques in sensor technology, data analytics, and controlled substance delivery represents a predictable technological extension that would be readily conceived by a skilled practitioner without requiring inventive insight.

Original Patent Information

Patent NumberUS 11,857,653
TitleMethod of providing an oral care benefit using a poorly-soluble calcium compound and fluoride
Assignee(s)Johnson & Johnson Consumer Inc.